EP3534922
ADENO-ASSOCIATED VIRUS FORMULATIONS
:
EP einkaleyfi: Þýðing ekki lögð inn:
3.11.2017:
17.4.2024:
17866366.2
:
2.11.2037
:
ADENO-ASSOCIATED VIRUS FORMULATIONS
3.11.2017
17.4.2024
:
Takeda Pharmaceutical Company Limited:
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, JP
:
FIEDLER, Christian:
1100 Vienna, AT
:
FRITSCHER, Eva:
1090 Vienna, AT
:
HASSLACHER, Meinhard:
1020 Vienna, AT
:
MITTERGRADNEGGER, Dominik:
1020 Vienna, AT
:
TABISH, Tanvir:
1210 Vienna, AT
:
201662417750 P:
4.11.2016:
US
:
US2017059971:
3.11.2017
:
C12N 15/86, A61K 35/76, A61P 7/00, A61K 9/00, A61K 9/19, A61K 47/02, A61K 47/18, A61K 31/195, A61K 47/22, A61K 47/26